| Autor: |
Ibrahimova V; Université Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, F-33600, Pessac, France., González-Delgado JA; Departamento de Química Orgánica, Universidad Autónoma de Madrid, 28049 Madrid, Spain., Levêque M; Université Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, F-33600, Pessac, France., Torres T; Departamento de Química Orgánica, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; IMDEA-Nanociencia, Campus de Cantoblanco, 28049 Madrid, Spain.; Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, 28049 Madrid, Spain., Garanger E; Université Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, F-33600, Pessac, France., Lecommandoux S; Université Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, F-33600, Pessac, France. |
| Abstrakt: |
Stimuli-responsive recombinant elastin-like polypeptides (ELPs) are artificial protein polymers derived from the hydrophobic domain of tropoelastin that have attracted significant interest for drug delivery and tissue engineering applications. In the present study, we have conjugated a photosensitizer (PS) to a hydrophobic methionine-containing ELP scaffold, which upon reaction with singlet oxygen ( 1 O 2 ) is transformed into a hydrophilic sulfoxide derivative facilitating the disassembly of photosensitizer-delivery particles during the photodynamic therapy (PDT) process. A peripherally substituted carboxy-Zn(II)-phthalocyanine derivative (TT1) bearing a carboxyl group directly linked to the Pc-ring, and presenting an absorption maximum around 680 nm, was selected as PS which simultaneously acted as a photooxidation catalyst. A TT1 -ELP[M 1 V 3 - 40 ] conjugate was prepared from ELP[M 1 V 3 - 40 ] modified with an alkyne group at the N -terminal chain end, and from TT1-amide-C3-azide by copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reaction. This innovative model photooxidation sensitive PS delivery technology offers promising attributes in terms of temperature-controlled particle formation and oxidation-triggered release, narrow molar mass distribution, reproducibility, scalability, non-immunogenicity, biocompatibility, and biodegradability for pharmaceutical applications in an effort to improve the clinical effectiveness of PDT treatments. |
